CN103800437A - Traditional Chinese medicine for treating entomophthoromycosis - Google Patents

Traditional Chinese medicine for treating entomophthoromycosis Download PDF

Info

Publication number
CN103800437A
CN103800437A CN201310752806.1A CN201310752806A CN103800437A CN 103800437 A CN103800437 A CN 103800437A CN 201310752806 A CN201310752806 A CN 201310752806A CN 103800437 A CN103800437 A CN 103800437A
Authority
CN
China
Prior art keywords
parts
chinese medicine
entomophthoromycosis
traditional chinese
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310752806.1A
Other languages
Chinese (zh)
Inventor
汤昌学
刘冬君
刘传华
杨士云
陈雄贵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhu Leruisi Information Consulting Co Ltd
Original Assignee
Wuhu Leruisi Information Consulting Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhu Leruisi Information Consulting Co Ltd filed Critical Wuhu Leruisi Information Consulting Co Ltd
Priority to CN201310752806.1A priority Critical patent/CN103800437A/en
Publication of CN103800437A publication Critical patent/CN103800437A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine for treating entomophthoromycosis, belonging to the technical field of traditional Chinese medicines. The traditional Chinese medicine for treating entomophthoromycosis is characterized in that a raw pharmaceutical material of the traditional Chinese medicine contains the following ingredients in parts by weight: 6-15 parts of balloon flower root, 10-25 parts of dandelion, 6-12 parts of honeysuckle flower, 10-20 parts of dahurian angelica root, 6-10 parts of selfheal spike and 6-15 parts of toad. The traditional Chinese medicine preparation disclosed by the invention is safe, reliable and effective and is free from toxic and side effects.

Description

A kind of Chinese medicine for the treatment of entomophthoromycosis
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of entomophthoromycosis, belong to technical field of Chinese medicines.
Background technology
Entomophthoromycosis be take nasal mucosa polyp and widely palp subcutaneous localized mass as feature, pathogen is crown entomophthora (Conidiobolus coronatus), infection is initiated at nasal septum, gradually to nasal sinuses, the subcutaneous tissue in throat and center of face district, concha nasalis swelling before when onset, make progress slower, occasionally can make fast progress and involve mucosa, nostril, oral area and nasal sinuses, pathological changes is often bilateral, occasionally can be one-sided, lump expands can cause adjacent tissue's Silent Neuritis damage, in tissue, mycelia is more easily dyeed by HE, but PAS, easy coloring not of Gridly, CMS dyeing also a little less than, single or the cluster of mycelia, average diameter 8 μ m, isolation rule, wall is thinner, but more easily confirm, around with bright radial, what have granule has a liking for Yihong material, 2~6 μ m are thick, this has a liking for Yihong material and is finger-like or starlike arrangement, similar sporotrichosis aster, mycelia is not invaded blood vessel wall.
What treat clinically at present that entomophthoromycosis mainly adopts is potassium iodide, steroid and trimethoprim treatment, but the course for the treatment of is longer, and patient's health has often been produced to larger toxic and side effects, and therapeutic effect is undesirable.
Summary of the invention
The present invention aims to provide the Chinese medicine of a kind of safe and reliable, evident in efficacy, treatment no pain, the treatment entomophthoromycosis that has no side effect, and this Chinese medicine, by selecting rationally effectively raw medicinal material and proportioning thereof, reaches the object of safe and effective healing entomophthoromycosis.
The present invention is achieved by the following technical solutions:
Treat a Chinese medicine for entomophthoromycosis, special character is, formulated by the crude drug of following weight proportion: Radix Platycodonis 6-15 part, Herba Taraxaci 10-25 part, Flos Lonicerae 6-12 part, Radix Angelicae Dahuricae 10-20 part, Spica Prunellae 6-10 part, Bufo siccus 6-15 part.
More excellent raw material components is chosen as: 8 parts of Radix Platycodoniss, 15 parts of Herba Taraxacis, 8 parts of Flos Loniceraes, 15 parts of the Radixs Angelicae Dahuricae, 8 parts of Spica Prunellaes, 8 parts of Bufo siccuss.
Radix Platycodonis: be the dried roots of Campanulaceae Radix Platycodonis, bitter in the mouth, pungent, slightly warm in nature.Enter lung meridian.Energy expelling phlegm for arresting cough, and have lung qi dispersing, evacuation of pus effect.Lung qi dispersing, eliminate the phlegm, sore-throat relieving, evacuation of pus, sharp the five internal organs, fill blood, mend five kinds of over strain, foster the spirit of nobility.Cure mainly cough with copious phlegm, laryngopharynx swelling and pain, lung abscess vomiting pus, fullness in the chest and hypochondriac pain, dysentery stomachache, aphtha of the mouth and tongue, conjunctival congestion and swelling pain, uroschesis.
Herba Taraxaci: the agglomerate of Chinese traditional drug taraxacum herb crinkle song, root is cylindrical, many bending long 3~7cm, sepia, root head has fine hair, leaf fragmentation, intact leaf is for falling lanceolar, the green or green and brown color of dull gray, and edge is shallow to be split or has pinniform and incise, the downward one-tenth handle of base portion shape, lower surface master pulse is obvious, and scape 1 is to several, head inflorescence top is raw, yellowish-brown or yellowish white, and the visible majority having has the oblong achene of white pappus, feeble QI, mildly bitter flavor.Sweet, micro-hardship, cold.Heat-clearing and toxic substances removing, dispersing swelling and dissipating binds.Upper respiratory tract infection, eye conjunctivitis, mumps, hyperglycemia, acute mastitis swells and ache, gastritis, dysentery, hepatitis, gallbladder is assisted inflammation, acute appendicitis, urinary system infection, pelvic inflammatory disease, carbuncle furuncle furuncle, pharyngitis, controls acute mastitis, lymphadenitis, scrofula, furuncle carbuncle toxin, acute conjunctivitis, cold, fever, acute tonsillitis, acute bronchitis, urinary tract infection.
Flos Lonicerae: sweet, micro-hardship, delicate fragrance, pungent, cold.Return lung, stomach, the heart, large intestine channel.For Caprifoliaceae woodbine Radix Ophiopogonis and congener dry flower or the first flower of opening of band.Flos Lonicerae is described as the good medicine of heat-clearing and toxic substances removing from ancient times.The sweet cold fragrance of its property, clearing away heat with drugs sweet in flavor and cold in nature and not injuring one's stomach, fragrance thoroughly reaches and can be eliminating evil.Flos Lonicerae can dispelling wind-heat, also kind removing summer-heat blood poison, and for various febrile diseases, as fever of the body, dermexanthesis, send out the cards such as speckle, pyretic toxicity carbuncle sore, laryngopharynx swelling and pain, all effect is remarkable.
The Radix Angelicae Dahuricae: warm in nature, acrid in the mouth.Wind-damp dispelling, the evacuation of pus of invigorating blood circulation, granulation promoting pain relieving.For headache, toothache, nasal sinusitis, hemorrhoidal hamorrhage anal fistula, leucorrhea with red and white discharge, ulcer sores, skin pruritus.The cold expelling that induces sweat, wind-expelling pain-stopping, clearing the nasal passage, dampness leukorrhagia stopping, detumescence and apocenosis.Control headache, supraorbital bone pain, toothache, nasal sinusitis, cold-damp stomachache, hemorrhoidal hamorrhage anal fistula, leucorrhea with red and white discharge, ulcer sores, skin pruritus due to dryness, scabies.Expelling pathogenic wind from the body surface: for cold, the cards such as headache, nasal obstruction, have dispersing wind and cold, an effect of the pain that relieves the pain.Wind-expelling pain-stopping: for wind syndrome of head pain, migraine, supraorbital bone pain, nasosinusitis headache, tooth pain etc., can wind-expelling pain-stopping.Dissipation evacuation of pus: with controlling carbuncle skin infection, from the beginning of dissipating, can evacuation of pus after bursting.A surname's clearing the nasal passage: for the long stream of turbid tears of nasal sinusitis, anosmia person.
Spica Prunellae: cold in nature, sweet in the mouth, pungent, micro-hardship, there is the effect of letting out clearly liver-fire, mass dissipating and swelling eliminating, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, cooling blood for hemostasis, be applicable to lymphoid tuberculosis, goiter, acute mastitis, the vertigo, facial hemiparalysis, bones and muscles pain, pulmonary tuberculosis, metrorrhagia, leukorrhagia, Fiedeler's disease type hepatitis and bacillary dysentery etc.
Bufo siccus: acrid in the mouth; Cool in nature; GUIXIN; Liver; Spleen; Lung meridian.Detoxicating and resolving stagnation of pathogens; Removing food stagnancy diuretic; Destroying parasites for curing malnutrition.Main dysentery cellulitis; Furuncle; Carbuncle on the back; Scrofula; Malignant boil; The lump in the abdomen hypochondriac lump; Expand; Edema; Infantile malnutrition; Tetanus; Chronic cough and asthma.
Below in conjunction with clinical experiment data declaration beneficial effect of the present invention:
1, physical data
Inventor has collected the out-patient of 70 routine entomophthoromycosises altogether between year JIUYUE from May, 2010 to 2012, wherein male 45 examples, female's 25 examples, age 35-66 year, the course of disease 15 days to 1 month.70 routine patients are divided at random: treatment group 50 examples, matched group 20 examples.Two groups of patients' the data such as age, the course of disease, without significant difference, has comparability.
2, test method
2.1, the routine oral trimethoprim treatment of matched group 20, by specification is taken, 15 days courses for the treatment of.
2.2, treatment group 50 example adopts oral patent medicine of the present invention, the morning, noon and afternoon respectively once, 15 days courses for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1, criterion of therapeutical effect
Recovery from illness: clinical symptoms all disappears, and lab testing project is normal.Take a turn for the better: clinical symptom relief, lab testing improves or be normal.Invalid: clinical symptoms is without being clearly better or increasing the weight of, and lab testing is without improvement.
3.2, treatment statistical result is in table 1
The Comparison of therapeutic of table 1 treatment group and matched group
Group Case load Recovery from illness Take a turn for the better Invalid Total effective rate (%)
Treatment group 50 32(64%) 15(30%) 3(6%) 96%
Matched group 20 10(50%) 3(15%) 7(35%) 65%
Show by above-mentioned experimental data, the medicine that the present invention makes can be pacified effective treatment entomophthoromycosis entirely.
The specific embodiment
In order to understand better and to implement the present invention, below in conjunction with the specific embodiment, be used for formation of the present invention to be further described.
Embodiment 1
Take: 6 grams of Radix Platycodoniss, 10 grams of Herba Taraxacis, 6 grams of Flos Loniceraes, 10 grams of the Radixs Angelicae Dahuricae, 6 grams of Spica Prunellaes, 6 grams of Bufo siccuss, the decocting that adds 6 times of amounts boils 1.5-2 hour, filtrate for later use after filtration, the decocting that filtering residue adds 6 times of amounts again boils 1-1.5 hour, the filtrate of filtering and the filtrate of last time merge, after concentrated, carry out dry packing, must meet the powder of one day consumption of normal adult.
Instructions of taking and dose are: morning, noon and afternoon every day take for three times.
Embodiment 2
Take: 15 grams of Radix Platycodoniss, 25 grams of Herba Taraxacis, 12 grams of Flos Loniceraes, 20 grams of the Radixs Angelicae Dahuricae, 10 grams of Spica Prunellaes, 15 grams of Bufo siccuss, the decocting that adds 6 times of amounts boils 1.5-2 hour, filtrate for later use after filtration, the decocting that filtering residue adds 6 times of amounts again boils 1-1.5 hour, the filtrate of filtering and the filtrate of last time merge, and after concentrating, are dried, and then add appropriate dextrin and correctives, after granulating according to this area common process, pack, must meet the granule of one day consumption of normal adult.
Embodiment 3
Take: 10 grams of Radix Platycodoniss, 18 grams of Herba Taraxacis, 9 grams of Flos Loniceraes, 16 grams of the Radixs Angelicae Dahuricae, 8 grams of Spica Prunellaes, 8 grams of Bufo siccuss.Preparation method is with embodiment 2.

Claims (2)

1. a Chinese medicine for the treatment of entomophthoromycosis, is characterised in that, formulated by the crude drug of following weight proportion: Radix Platycodonis 6-15 part, Herba Taraxaci 10-25 part, Flos Lonicerae 6-12 part, Radix Angelicae Dahuricae 10-20 part, Spica Prunellae 6-10 part, Bufo siccus 6-15 part.
2. a kind of Chinese medicine for the treatment of entomophthoromycosis as claimed in claim 1, is characterised in that, formulated by the crude drug of following weight proportion: 8 parts of Radix Platycodoniss, 15 parts of Herba Taraxacis, 8 parts of Flos Loniceraes, 15 parts of the Radixs Angelicae Dahuricae, 8 parts of Spica Prunellaes, 8 parts of Bufo siccuss.
CN201310752806.1A 2013-12-31 2013-12-31 Traditional Chinese medicine for treating entomophthoromycosis Pending CN103800437A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310752806.1A CN103800437A (en) 2013-12-31 2013-12-31 Traditional Chinese medicine for treating entomophthoromycosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310752806.1A CN103800437A (en) 2013-12-31 2013-12-31 Traditional Chinese medicine for treating entomophthoromycosis

Publications (1)

Publication Number Publication Date
CN103800437A true CN103800437A (en) 2014-05-21

Family

ID=50698132

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310752806.1A Pending CN103800437A (en) 2013-12-31 2013-12-31 Traditional Chinese medicine for treating entomophthoromycosis

Country Status (1)

Country Link
CN (1) CN103800437A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105497296A (en) * 2014-10-29 2016-04-20 张祖宇 Traditional Chinese medicine for treating entomophthoromycosis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101511360A (en) * 2006-07-13 2009-08-19 美国加州大学洛杉矶海滨分校医学中心的洛杉矶生物医学研究所 Compositions and method for the treatment of mucormycosis and other epiphyte diseases
WO2010014728A1 (en) * 2008-07-29 2010-02-04 Frontier Scientific Inc. Use of tetrakis (n-alkylpyridinium) -porphyrin derivatives for killing microbes or preventing growth
CN102083425A (en) * 2008-04-22 2011-06-01 东北大学 Methods of treating fungal infections

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101511360A (en) * 2006-07-13 2009-08-19 美国加州大学洛杉矶海滨分校医学中心的洛杉矶生物医学研究所 Compositions and method for the treatment of mucormycosis and other epiphyte diseases
CN102083425A (en) * 2008-04-22 2011-06-01 东北大学 Methods of treating fungal infections
WO2010014728A1 (en) * 2008-07-29 2010-02-04 Frontier Scientific Inc. Use of tetrakis (n-alkylpyridinium) -porphyrin derivatives for killing microbes or preventing growth

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A.RAMESH,等: "Entomophthoromycosis of the Nose and Paranasal Simus", 《CLINICAL BRIEF》 *
杨秀敏,等: "虫霉病", 《国际皮肤性病学杂志》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105497296A (en) * 2014-10-29 2016-04-20 张祖宇 Traditional Chinese medicine for treating entomophthoromycosis

Similar Documents

Publication Publication Date Title
CN100434107C (en) Acne clearing decoction
CN102836228B (en) Chinese medicinal composition for treating conjunctivitis and preparation method and application thereof
CN103182023A (en) Medicine for treating chronic pharyngitis and preparation method thereof
CN103156984B (en) Traditional Chinese medicine composition for treating gingivitis and preparation method thereof
CN103877429B (en) A kind of Chinese medicine preparation and preparation method for the treatment of sinusitis
CN102327452A (en) Chinese patent medicament and Chinese decoction for treating initial carbuncle
CN102266474A (en) Honeysuckle flower and golden thread detoxicating capsules
CN103182064A (en) Medicine for treating cough due to wind-cold evil and preparation method thereof
CN111588828A (en) Chinese medicinal preparation for treating new coronavirus and viral diseases, and its preparation method
CN103830657A (en) Medicine for treating chronic cholecystitis
CN102940808A (en) Prescription medicine for treating lung cancer and preparation method
CN105535495A (en) Chinese medicinal composition for treating esophageal cancer by reinforcing vital essence and strengthening primordial qi and preparation method
CN104069443A (en) Traditional Chinese medicine for treating acute purulent osteomyelitis and preparation method of traditional Chinese medicine
CN103800437A (en) Traditional Chinese medicine for treating entomophthoromycosis
CN103800436A (en) Traditional Chinese medicine for treating entomophthoromycosis
CN103784796A (en) Chinese medicinal preparation for treating simple goiter
CN103919888B (en) A kind of compound hair oil and preparation method thereof
CN109966442B (en) Oral and external traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof
CN103705639B (en) One treats hydrocephalic Chinese medicine preparation
CN104958757A (en) Pressure sore paste and preparation method thereof
CN104825903A (en) Traditional Chinese medicine for treating mumps and method for manufacturing traditional Chinese medicine
CN102940753A (en) Pills for treating glaucoma and preparation method
CN102973744A (en) Ointment for external use for mixed hemorrhoids care
CN102670922A (en) Chinese medicine oral fluid with seeds of feather cockscomb for treating diarrhea and preparing method thereof
CN102247470B (en) A kind of Chinese medicine composition preventing and treating infant upper respiratory tract infection

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140521